{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:26:57Z","timestamp":1772166417996,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Some pain, fatigue, and gastrointestinal adverse events were observed in potential association with injection of COVID-19 vaccines, while there was no preventive intervention for it. We aim to investigate the efficacy of auricular acupressure (AA) therapy in preventing and relieving AEFI after injection of COVID-19 vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study design is a randomized, multicentre, three-arm controlled, single-blind trial. Participants meeting the inclusion criteria will be advertised and enrolled and assigned in the medical institutions randomly for post-injection observation. No less than 360 participants will be randomized into one of three groups: auricular acupressure group, sham auricular acupressure group, and wait-list group. Interventions will be performed immediately and will happen 4 to 5 times per day for 5\u2009days. The primary clinical outcomes will be quality and quantity evaluation among participants who reported any AEFI and who reported local pain at injection site. Secondary outcomes will concern headache, muscle and (or) joint pain, fatigue, nausea, vomiting, diarrhoea, and other potential events. All the outcomes will be assessed at baseline and 1, 3, 5, 7, and 14\u2009days after the injection. Both intention-to-treat and per-protocol analyses will be performed, with significance level determined as 5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Results of this trial will help to clarify the value of auricular acupressure therapy in preventing and relieving overall and certain adverse events following immunization after injection of COVID-19 vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      China Clinical Trial Registry (ChiCTR) (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=121519\">ChiCTR2100043210<\/jats:ext-link>\n                      ). Registered on 8 February, 2021.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-021-05837-x","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T06:02:43Z","timestamp":1637992963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Auricular acupressure for adverse events following immunization related to COVID-19 vaccine injection: study protocol for a multicenter, three-arm, blinded randomized controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Qinwei","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maolan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanwen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-0277","authenticated-orcid":false,"given":"Qinxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"key":"5837_CR1","volume-title":"Weekly epidemiological update on COVID-19","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19, 2021. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19-5-october-2021."},{"issue":"27","key":"5837_CR2","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1056\/NEJMe2034717","volume":"383","author":"EJ Rubin","year":"2020","unstructured":"Rubin EJ, Longo DL. SARS-CoV-2 vaccination - an ounce (actually, much less) of prevention. N Engl J Med. 2020;383(27):2677\u20138. https:\/\/doi.org\/10.1056\/NEJMe2034717.","journal-title":"N Engl J Med."},{"key":"5837_CR3","volume-title":"Vaccines for COVID-19","author":"Center for Disease Control and Prevention(CDC)","year":"2021","unstructured":"Center for Disease Control and Prevention(CDC). Vaccines for COVID-19. 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/index.html."},{"issue":"2","key":"5837_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59\u2009years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial. Lancet Infect Dis. 2021;21(2):181\u201392. https:\/\/doi.org\/10.1016\/S1473-3099(20)30843-4.","journal-title":"Lancet Infect Dis."},{"issue":"10","key":"5837_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2020.15543","volume":"324","author":"S Xia","year":"2020","unstructured":"Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, et al. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA. 2020;324(10):951\u201360. https:\/\/doi.org\/10.1001\/jama.2020.15543.","journal-title":"JAMA."},{"issue":"5","key":"5837_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med."},{"issue":"10285","key":"5837_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","volume":"397","author":"E Vasileiou","year":"2021","unstructured":"Vasileiou E, Simpson CR, Shi T, Kerr S, Agrawal U, Akbari A, et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397(10285):1646\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(21)00677-2.","journal-title":"Lancet."},{"key":"5837_CR8","doi-asserted-by":"publisher","unstructured":"Collier DA, De Marco A, Ferreira IATM, et al. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-021-03412-7.","DOI":"10.1038\/s41586-021-03412-7"},{"issue":"15","key":"5837_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1056\/NEJMc2102017","volume":"384","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu J, Xia H, Zhang X, Fontes-Garfias CR, Swanson KA, et al. Neutralizing activity of BNT162b2-elicited serum. N Engl J Med. 2021;384(15):1466\u20138. https:\/\/doi.org\/10.1056\/NEJMc2102017.","journal-title":"N Engl J Med."},{"key":"5837_CR10","doi-asserted-by":"publisher","unstructured":"Choi A, Koch M, Wu K, et al. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis [published online ahead of print, 2021 Sep 15]. Nat Med. 2021;10. https:\/\/doi.org\/10.1038\/s41591-021-01527-y.","DOI":"10.1038\/s41591-021-01527-y"},{"key":"5837_CR11","doi-asserted-by":"publisher","unstructured":"Levin EG, Lustig Y, Cohen C, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6\u2009months [published online ahead of print, 2021 Oct 6]. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2114583.","DOI":"10.1056\/NEJMoa2114583"},{"key":"5837_CR12","doi-asserted-by":"publisher","unstructured":"Chemaitelly H, Tang P, Hasan MR, et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar [published online ahead of print, 2021 Oct 6]. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2114114.","DOI":"10.1056\/NEJMoa2114114"},{"issue":"1","key":"5837_CR13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1080\/22221751.2021.1969291","volume":"10","author":"XN Li","year":"2021","unstructured":"Li XN, Huang Y, Wang W, Jing QL, Zhang CH, Qin PZ, et al. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Emerg Microbes Infect. 2021;10(1):1751\u20139. https:\/\/doi.org\/10.1080\/22221751.2021.1969291.","journal-title":"Emerg Microbes Infect."},{"key":"5837_CR14","doi-asserted-by":"publisher","unstructured":"Tartof SY, Slezak JM, Fischer H, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6\u2009months in a large integrated health system in the USA: a retrospective cohort study [published online ahead of print, 2021 Oct 4]. Lancet. 2021. https:\/\/doi.org\/10.1016\/S0140-6736(21)02183-8.","DOI":"10.1016\/S0140-6736(21)02183-8"},{"key":"5837_CR15","volume-title":"COVID-19 vaccine tracker and landscape","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. COVID-19 vaccine tracker and landscape. 2021. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"5837_CR16","volume-title":"Pfizer-BioNTech COVID-19 vaccine overview and safety (also known as COMIRNATY)","author":"Center for Disease Control and Prevention (CDC)","year":"2021","unstructured":"Center for Disease Control and Prevention (CDC). Pfizer-BioNTech COVID-19 vaccine overview and safety (also known as COMIRNATY). 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/Pfizer-BioNTech.html."},{"issue":"2","key":"5837_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225\u20138. https:\/\/doi.org\/10.1038\/s41591-020-1124-9.","journal-title":"Nat Med."},{"key":"5837_CR18","doi-asserted-by":"publisher","first-page":"103854","DOI":"10.1016\/j.ijnurstu.2020.103854","volume":"114","author":"KO Kwok","year":"2021","unstructured":"Kwok KO, Li KK, Wei WI, et al. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021;114:103854. https:\/\/doi.org\/10.1016\/j.ijnurstu.2020.103854.","journal-title":"Int J Nurs Stud."},{"issue":"45","key":"5837_CR19","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1016\/j.vaccine.2020.09.041","volume":"38","author":"M Detoc","year":"2020","unstructured":"Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.041.","journal-title":"Vaccine."},{"key":"5837_CR20","doi-asserted-by":"publisher","first-page":"669339","DOI":"10.3389\/fimmu.2021.669339","volume":"12","author":"Q He","year":"2021","unstructured":"He Q, Mao Q, Zhang J, Bian L, Gao F, Wang J, et al. COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations. Front Immunol. 2021;12:669339. https:\/\/doi.org\/10.3389\/fimmu.2021.669339.","journal-title":"Front Immunol."},{"key":"5837_CR21","volume-title":"Safety Monitoring of an Additional Dose of COVID-19 Vaccine \u2014 United States, August 12\u2013September 19, 2021","author":"Center for Disease Control and Prevention (CDC)","year":"2021","unstructured":"Center for Disease Control and Prevention (CDC). Safety Monitoring of an Additional Dose of COVID-19 Vaccine \u2014 United States, August 12\u2013September 19, 2021. 2021. https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7039e4.htm?s_cid=mm7039e4_w."},{"issue":"3","key":"5837_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/life11030249","volume":"11","author":"AG Mathioudakis","year":"2021","unstructured":"Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, et al. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey. Life (Basel). 2021;11(3):249. https:\/\/doi.org\/10.3390\/life11030249.","journal-title":"Life (Basel)."},{"issue":"1","key":"5837_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13063-021-05138-3","volume":"22","author":"Q Fu","year":"2021","unstructured":"Fu Q, Xie H, Zhou L, et al. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Trials. 2021;22(1):162. Published 2021 Feb 25. https:\/\/doi.org\/10.1186\/s13063-021-05138-3.","journal-title":"Trials"},{"key":"5837_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ctcp.2016.06.006","volume":"24","author":"M Eghbali","year":"2016","unstructured":"Eghbali M, Yekaninejad MS, Varaei S, et al. The effect of auricular acupressure on nausea and vomiting caused by chemotherapy among breast cancer participants. Complement Ther Clin Pract. 2016;24:189\u201394. https:\/\/doi.org\/10.1016\/j.ctcp.2016.06.006.","journal-title":"Complement Ther Clin Pract."},{"issue":"1","key":"5837_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0193945916680362","volume":"40","author":"J Shin","year":"2018","unstructured":"Shin J, Park H. Effects of auricular acupressure on constipation in participants with breast cancer receiving chemotherapy: a randomized control trial. West J Nurs Res. 2018;40(1):67\u201383. https:\/\/doi.org\/10.1177\/0193945916680362.","journal-title":"West J Nurs Res."},{"issue":"1","key":"5837_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/bmjspcare-2019-001937","volume":"11","author":"L Lin","year":"2021","unstructured":"Lin L, Zhang Y, Qian HY, Xu JL, Xie CY, Dong B, et al. Auricular acupressure for cancer-related fatigue during lung cancer chemotherapy: a randomised trial. BMJ Support Palliat Care. 2021;11(1):32\u20139. https:\/\/doi.org\/10.1136\/bmjspcare-2019-001937.","journal-title":"BMJ Support Palliat Care."},{"issue":"2","key":"5837_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1875-4597(10)60018-5","volume":"48","author":"ML Yeh","year":"2010","unstructured":"Yeh ML, Tsou MY, Lee BY, Chen HH, Chung YC. Effects of auricular acupressure on pain reduction in participant-controlled analgesia after lumbar spine surgery. Acta Anaesthesiol Taiwan. 2010;48(2):80\u20136. https:\/\/doi.org\/10.1016\/S1875-4597(10)60018-5.","journal-title":"Acta Anaesthesiol Taiwan."},{"key":"5837_CR28","doi-asserted-by":"publisher","first-page":"7279486","DOI":"10.1155\/2020\/7279486","volume":"2020","author":"ZH Zhao","year":"2020","unstructured":"Zhao ZH, Zhou Y, Li WH, Tang ZH, Xia TW, Han-Li. Auricular acupressure in participants with hypertension and insomnia: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2020;2020:7279486\u201311. https:\/\/doi.org\/10.1155\/2020\/7279486.","journal-title":"Evid Based Complement Alternat Med."},{"issue":"1","key":"5837_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JNR.0000000000000209","volume":"26","author":"KH Chueh","year":"2018","unstructured":"Chueh KH, Chang CC, Yeh ML. Effects of auricular acupressure on sleep quality, anxiety, and depressed mood in RN-BSN students with sleep disturbance. J Nurs Res. 2018;26(1):10\u20137. https:\/\/doi.org\/10.1097\/JNR.0000000000000209.","journal-title":"J Nurs Res."},{"issue":"1","key":"5837_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s13063-019-3865-7","volume":"20","author":"S Treweek","year":"2019","unstructured":"Treweek S. Protocols-more structure, less \u2018Wuthering Heights\u2019. Trials. 2019;20(1):649. https:\/\/doi.org\/10.1186\/s13063-019-3865-7.","journal-title":"Trials."},{"key":"5837_CR31","volume-title":"Guideline for Thchniques of COVID-19 Vaccine Injection(First Edition)","author":"National Health Commission of the People\u2019s Republic of China","year":"2021","unstructured":"National Health Commission of the People\u2019s Republic of China. Guideline for Thchniques of COVID-19 Vaccine Injection(First Edition). 2021. https:\/\/zwfw.nhc.gov.cn\/kzx\/zcfg\/zcfgqb\/."},{"key":"5837_CR32","volume-title":"Auricular medicine: a complete manual of auricular diagnosis and treatment","author":"LC Huang","year":"2005","unstructured":"Huang LC. Auricular medicine: a complete manual of auricular diagnosis and treatment. 1st ed. Orlando: Auricular International Research & Training; 2005.","edition":"1"},{"issue":"2","key":"5837_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/rapm-2020-102088","volume":"46","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Huang Y, Li H, Yan Z, Zhang Y, Liu X, et al. Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study. Reg Anesth Pain Med. 2021;46(2):145\u201350. https:\/\/doi.org\/10.1136\/rapm-2020-102088.","journal-title":"Reg Anesth Pain Med."},{"key":"5837_CR34","volume-title":"Nomenclature and location of auricular points, GB\/T 13734-2008. National Administration of Traditional Chinese Medicine of China","author":"L Zhou","year":"2008","unstructured":"Zhou L, Zhao B, National Technical Committee on Acupuncture and Moxibustion of Standardization Administration of China. Nomenclature and location of auricular points, GB\/T 13734-2008. National Administration of Traditional Chinese Medicine of China, 2008. (http:\/\/c.gb688.cn\/bzgk\/gb\/showGb?type=online&hcno=D6A125ED4011A9A625F8A3ACE425EE09)"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05837-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T15:04:17Z","timestamp":1665587057000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05837-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["5837"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05837-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-966861\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Medical Ethics Committee of Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China, on February 2, 2021, with certificate No. 2021KL-015. Before inclusion in the study, participants will be informed of the purpose of the study and of the clinical procedures required by the protocol. The investigators in each hospital will explain the purpose, risks, and benefits associated with study participation. In addition, participants will be informed of their right to withdraw from the study at any time without explanation and without losing the right to future medical care. Every participant is free to leave the study protocol at any stage of the study, may withdraw his or her consent, and may request that all of his or her data be eliminated from the database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"No baseline or pilot data is included in this study protocol. Figure\n                      \n                      shows distribution of the auricular acupoints selected in our study on the surface of auricle, and it was approved by one of our authors (Zhiqiao Wang, whose auricle is showed in the Fig.\n                      \n                      ) with informed consent signed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"857"}}